The Report Guru

The global overactive bladder treatment market is projected to reach USD 4.2 Billion by 2027 from USD 3.5 Billion in 2022, at a CAGR of 3.6% during the forecast period Major factors driving the market growth are rising prevalence of overactive bladder syndrome across the globe. Furthermore, launch of novel drugs with lesser side-effects coupled with adoption of technologically advanced treatment options for OAB treatment are also expected to support market growth in the coming years. Overactive bladder treatment market is fragmented and competitive in nature, several market players are adopting strategies to sustain market competition. The company offerings range from, various drugs, devices and botox that have larger geographic reach along with high product flexibility. Prominent players in the global overactive bladder treatment market are Astellas Pharma (Japan), Teva Pharmaceutical Industries (Israel), Pfizer (US), Medtronic (Ireland), AbbVie (US), Viatris (US), Hisa

The global Digital PCR Market is highly competitive. The market is estimated to grow to USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0%. Factors such as the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use. The global dPCR and qPCR market is highly competitive, with many large, medium-sized, and small market players. As of the financial year ended in March 2019, the global Digital PCR Market was dominated by Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland). Thermo Fisher Scientific held the leading po

The US healthcare environmental services market is projected to reach USD 8.7 billion by 2026 from USD 6.6 billion in 2021, at a CAGR of 5.8% during the forecast period. Growth in the market is majorly driven by stringent government regulations for effective infection control, advancements in cleaning technology, and the rising prevalence of HAIs. With a surge in COVID-19 cases, there is an increasing focus on hygiene & control practices and the rising need to reduce the spread of infection, thus supporting the market growth. The prominent players operating in this US healthcare environmental services market include Sodexo Global (France), Compass Group (UK), Aramark Corporation (US), Hospital Housekeeping Systems, Inc. (HHS) (US), ABM Industries Incorporated (US), Xanitos, Inc. (US), OctoClean Franchising Systems, Inc. (US), AVI Foodsystems, Inc. (US), Jani-King International, Inc. (US), Healthcare Services Group, Inc. (US), ServiceMaster Clean (US), Bravo Building

The antimicrobial susceptibility testing market is projected to reach USD 4.7 Billion in 2027 from 3.6 Billion in 2022 at a CAGR of 5.5% during the forecast period. The high prevalence of infectious diseases, rising government funding and initiatives for antimicrobial susceptibility testing programs, technological developments for the creation of new AST methods, and the emergence of multidrug resistance in microorganisms are the main factors driving the antimicrobial susceptibility testing market. However, strict government controls are anticipated to limit this market's expansion to some degree. Players in the antimicrobial susceptibility testing market may anticipate having tremendous growth potential as a result of emerging markets and ongoing R&D to provide quick antimicrobial susceptibility testing. The Antimicrobial susceptibility testing market is moderately competitive, with both established companies and upcoming competitors for the same market share. A

The global hyperspectral imaging systems market is projected to reach USD 42.3 billion by 2027 from USD 18.1 billion in 2022, at a CAGR of 18.5% during the forecast period. Market growth can largely be attributed to factors such as increasing funding and investments in this field and the growing industrial applications of hyperspectral imaging. Emerging markets in developing economies are expected to offer potential growth opportunities for players operating in the market. The hyperspectral imaging systems market is segmented based on product, technology, application, and region The global hyperspectral imaging systems market is highly competitive and fragmented. The prominent players operating in this market include Headwall Photonics, Inc. (US), Applied Spectral Imaging, Inc. (US), Corning Incorporated (US), Surface Optics Corporation (US), Norsk Elektro Optikk AS (Norway), Resonon, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Telops, Inc. (Canada), BaySpec, Inc

The global spatial genomics and transcriptomics market is projected to reach USD 800 million by 2027 from USD 355 million in 2022, at a CAGR of 17.6% during the forecast period. Market growth is largely driven by the increasing development in the area such as neurodegenerative diseases and cancer. Along with this, launch of several advanced products are contributing towards the growth of the market. On the other hand, need of high initial investments, and dearth of skilled professionals are some factors limiting the market growth. The market for spatial genomics & transcriptomics is highly consolidated, with key players strategizing to capture the market. Prominent players in the market are NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), Danaher Corporation (US), Natera, Inc. (US), PerkinElmer, Inc. (US),

The global liquid biopsy market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% during the forecast period. Growth in the liquid biopsy market is mainly driven by factors such as the rising incidence and prevalence of cancer, awareness initiatives undertaken by global health organizations, and the increasing preference for noninvasive treatment procedures. However, the lower sensitivity of certain liquid biopsies might act as a restraining factor to the growth of this market. The key players in the liquid biopsy market are F. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US), MDxHealth SA (Belgium), Exact Sciences Corporation (US), Illumina Inc. (US), Sysmex Inostics (US), Bio-Rad Laboratories, Inc. (US), Biocept, Inc. (US), NeoGenomics, Inc. (US), ANGLE plc (UK), Menarini-Silicon Biosystems (Italy), Vortex Biosciences

The global single use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. The growth of this market is mainly driven by the increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D. The prominent players operating in the single use bioreactors market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany). Sartorius Stedim Biotech held the leading position in the single-use bioreactors market in 2019. Sartorius focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and expansions. During the past three years, Sartorius Stedim Bio

The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2026. Market growth is largely driven by the rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests. However, the high degree of consolidation in the by the major market players is expected to restrain the growth of this market during the forecast period. Leading market players The global immunohistochemistry market is highly competitive. Prominent players operating in the global immunohistochemistry market include F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product launches and approvals to expand their product and geogra

The global remote patient monitoring market is projected to reach USD 175.2 Billion by 2027 from USD 53.6 Billion in 2022, at a CAGR of 26.7% during the forecast period. The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden on medical resources, advancements in telecommunications, growing incidences of chronic diseases, and increasing investments in telehealth and RPM are the major factors driving the growth of this market. However, the regulatory variations across regions, healthcare fraud, and informal usage of social media practices is expected to restrain the market growth during the forecast period. The prominent players operating in the remote patient monitoring market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers AG (Germany), OMRON Healthcare (Japan), Bosto

  The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% during the forecast period Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. However, product recalls and high procedural costs likely to challenge market growth in the coming years. Drivers: growing number of surgical procedures performed The increasing number of surgical procedures performed worldwide is a major driver of the pain management devices market. The growing prevalence of chronic conditions, such as cancer and neurological disorders, has led to an increased demand for surgical inter

Antimicrobial susceptibility testing (AST) is a laboratory procedure used to determine which antibiotics will be most effective in treating a particular bacterial infection. The test involves exposing the bacteria to a range of antibiotics to see which ones are able to inhibit or kill the growth of the organism. The global antimicrobial susceptibility testing market is expected to reach USD 4.7 billion by 2027, growing at a CAGR of 5.5% during the forecast period (2022-2027). The market growth can be attributed to the increasing prevalence of infectious diseases, rising healthcare expenditure, and growing demand for new and advanced antimicrobial susceptibility testing techniques. Factors Driving the Antimicrobial Susceptibility Testing Market ◉Rising Prevalence of Infectious Diseases The increasing prevalence of infectious diseases such as pneumonia, tuberculosis, and urinary tract infections is one of the key factors driving the antimicrobial susceptibility testing marke

Healthcare IT consulting is a service provided to healthcare organizations to help them effectively manage and utilize their technology resources. The service involves the implementation of various software solutions, such as electronic health records (EHRs) and patient engagement platforms, to improve the delivery of patient care and streamline administrative processes. The global healthcare IT consulting market is expected to grow at a CAGR of 19.8%. The market growth can be attributed to the increasing adoption of healthcare IT solutions, rising government initiatives to promote healthcare IT adoption, and the growing need for healthcare organizations to manage their IT infrastructure more efficiently. Factors Driving the Healthcare IT Consulting Market ◉Increasing Adoption of Healthcare IT Solutions The adoption of healthcare IT solutions, such as EHRs and patient engagement platforms, is increasing rapidly. These solutions help healthcare organizations manage their p

The life sciences industry has been a rapidly growing sector of the economy in recent years, and with that growth has come an increased demand for life sciences analytics. Life sciences analytics is the process of collecting, analyzing, and interpreting data from various sources within the life sciences industry. This data can be used to identify trends, make predictions, and improve processes within the industry. The life sciences analytics market is estimated to be worth $47.5 billion by 2027, growing at a CAGR of 11.8% between 2022 to 2027. This growth is being driven by the increased demand for data-driven insights from life science organizations. Pharmaceutical companies, in particular, are looking to leverage analytics to improve drug development and marketing strategies. Additionally, advances in technology, such as artificial intelligence (AI) and machine learning (ML), are making it easier for life science organizations to access and analyze large amounts of dat

Contrast media, also known as contrast agents or contrast dyes, are substances used in medical imaging to enhance the visibility of internal structures or organs. They work by altering the way X-rays, magnetic fields, or ultrasound waves interact with the tissues in the body. Contrast media are commonly used in diagnostic imaging procedures such as X-rays, CT scans, MRI scans, and ultrasounds. In this blog, we will discuss the contrast media market, its trends, and the factors driving its growth. Market Overview: The global contrast media market was valued at $5.1 billion in 2022 and is expected to grow at a CAGR of 3.7% from 2022 to 2027 and projected to reach $6.1 billion by 2027. The increasing prevalence of chronic diseases, growing demand for minimally invasive diagnostic procedures, and technological advancements in imaging modalities are some of the key factors driving the growth of the contrast media market. The market is segmented into two main categories: iodin

Liquid biopsy is a non-invasive diagnostic technique that involves the detection of cancer biomarkers in the blood or other bodily fluids. It is a rapidly growing field, with the potential to revolutionize cancer diagnosis and treatment. In this blog, we will explore the liquid biopsy industry, its market size, and trends, as well as the factors driving the growth of the industry. Market Size and Trends The global liquid biopsy market size was valued at USD 4.3 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 18.3% from 2022 to 2027. The increasing prevalence of cancer, the growing adoption of liquid biopsy for early cancer detection, and the development of advanced liquid biopsy technologies are the key factors driving the growth of the liquid biopsy industry. Types of Liquid Biopsy There are two main types of liquid biopsy: circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). CTCs are cells that have detached from the prim

  Spirometry is a simple and non-invasive pulmonary function test that measures the amount and speed of air that can be exhaled from the lungs. Spirometry is used to diagnose and monitor lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. In this blog, we will explore the spirometer industry, its market size, and trends, as well as the factors driving the growth of the industry. Market Size and Trends The global spirometer market size was valued at USD 799 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.1% from 2020 to 2025. The increasing prevalence of respiratory diseases, such as asthma and COPD, and the growing aging population are the key factors driving the growth of the spirometer industry. In addition, the COVID-19 pandemic has also contributed to the growth of the spirometer industry, as spirometry is a critical tool in the diagnosis and management of COVID-19 patients with respir

The medical wearables market has been growing rapidly in recent years due to the increasing demand for remote patient monitoring, the rise in chronic diseases, and the integration of advanced technologies such as artificial intelligence and internet of things (IoT). The global medical wearables market is projected to reach USD 30.1 billion by 2026, growing at a CAGR of 13.2% during the forecast period of 2021-2026. This blog will discuss the key factors driving the growth of the medical wearables market. Rise in Chronic Diseases Chronic diseases such as diabetes, heart disease, and respiratory diseases are on the rise globally. According to the World Health Organization, chronic diseases are responsible for 71% of all deaths worldwide. Medical wearables can help to manage these chronic diseases by providing continuous monitoring of vital signs such as blood glucose levels, heart rate, and blood pressure. Medical wearables can also track the patient's physical activity

  Minimally invasive surgical instruments industry revolution Minimally invasive surgical instruments are a major advancement in modern medical technology. These instruments allow surgeons to perform complex procedures without having to make large incisions. This means that patients can often experience shorter hospital stays, fewer complications, and less post-operative pain. The minimally invasive surgical instruments industry is highly competitive, with many different manufacturers competing for market share. These manufacturers are constantly looking for ways to improve their products, such as developing new materials and technologies. For example, some instruments are now made from carbon fiber or titanium, which can be more precise and flexible than traditional steel instruments. The industry is also increasingly focused on the development of robotic instruments. These robots can be programmed to perform precise movements, allowing surgeons to make smaller incision